These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7681096)

  • 21. An autopsy report case of rape victim by the application of PSA test kit as a new innovation for sexual assault investigation in Thailand.
    Talthip J; Chirachariyavej T; Peonim AV; Atamasirikul K; Teerakamchai S
    J Med Assoc Thai; 2007 Feb; 90(2):348-51. PubMed ID: 17375642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive prostate-specific antigen (PSA) reaction in post-mortem rectal swabs: a cautionary note.
    Lunetta P; Sippel H
    J Forensic Leg Med; 2009 Oct; 16(7):397-9. PubMed ID: 19733329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enzyme-linked immunosorbent assay for serum prostate specific antigen (PSA) using monoclonal antibodies].
    Setoguchi C; Matsumoto K; Samori T; Kimura E; Harukaze S
    Rinsho Byori; 1998 Jan; 46(1):79-82. PubMed ID: 9492543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical utility of the free prostate specific antigen (PSA), alpha 1-antichymotrypsin-complexed PSA, and free/total PSA ratio using the specific and sensitive enzyme-linked immunosorbent assay "E-plate EIKEN PSA"].
    Imai K; Yamanaka H; Kubota Y; Miki M; Ito T; Akaza H; Uchida K; Egawa S; Kuriyama M; Watanabe H; Okihara K; Kotake T; Usami M; Arai Y; Maeda H; Sagiyama K; Saito Y; Sakai H; Shida K
    Hinyokika Kiyo; 1998 Oct; 44(10):755-63. PubMed ID: 9850846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
    Wan XS; Xu YA; Ware JH; Kennedy AR
    Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer.
    Kamoi K; Babaian RJ
    Semin Oncol; 1999 Apr; 26(2):140-9. PubMed ID: 10597725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group].
    Imai K; Watanabe K; Higashi H; Shinya H; Okamura K; Matsuo Y; Yazima H; Takezawa Y; Yamanaka H
    Hinyokika Kiyo; 1993 Sep; 39(9):807-12. PubMed ID: 7692709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
    Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F
    BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunologic sperm detection].
    Müller V; Hinkelmann G
    Arch Kriminol; 1991; 188(3-4):106-9. PubMed ID: 1722088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen detection by ultrasensitive assay in samples from women.
    Filella X; Molina R; Alcover J; Menéndez V; Giménez N; Jo J; Carretero P; Ballesta AM
    Prostate; 1996 Nov; 29(5):311-6. PubMed ID: 8899004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PSA quick test in capillary blood.
    Loertzer H; Fischer K; Fornara P
    Anticancer Res; 2005; 25(3A):1659-62. PubMed ID: 16033077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum keratinocyte growth factor measurement in patients with prostate cancer.
    Mehta PB; Robson CN; Neal DE; Leung HY
    J Urol; 2000 Dec; 164(6):2151-5. PubMed ID: 11061946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation.
    Gann PH; Ma J; Catalona WJ; Stampfer MJ
    J Urol; 2002 Jun; 167(6):2427-34. PubMed ID: 11992051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of reducing the prostate-specific antigen threshold and including isoform reflex tests on the performance characteristics of a prostate-cancer detection programme.
    Roddam AW; Hamdy FC; Allen NE; Price CP;
    BJU Int; 2007 Sep; 100(3):514-7. PubMed ID: 17542987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid and simple detection of a mycobacterium circulating antigen in serum of pulmonary tuberculosis patients by using a monoclonal antibody and Fast-Dot-ELISA.
    El-Masry S; El-Kady I; Zaghloul MH; Al-Badrawey MK
    Clin Biochem; 2008 Feb; 41(3):145-51. PubMed ID: 18082139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients.
    Beneduce L; Prayer-Galetti T; Giustinian AM; Gallotta A; Betto G; Pagano F; Fassina G
    Cancer Detect Prev; 2007; 31(5):402-7. PubMed ID: 18035503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of PSA and AP tests for the detection of spermatozoa in postmortem swabs from the genital and anal region in males.
    Weitzig L; Schroeder AS; Augustin C; Raupach T; Sehner S; Anders S
    J Forensic Sci; 2015 Jan; 60(1):41-4. PubMed ID: 25387394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml.
    Khan MA; Partin AW; Rittenhouse HG; Mikolajczyk SD; Sokoll LJ; Chan DW; Veltri RW
    J Urol; 2003 Sep; 170(3):723-6. PubMed ID: 12913682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.